“Dupilumab Improves Disease Control and Patient-Reported Outcomes in Adults With Atopic Dermatitis in Clinical Practice: Subgroup Analysis of Black African American Population from RELIEVE-AD”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 1, Jan. 2024, p. s327, https://doi.org/10.25251/skin.8.supp.327.